Skip to main content

Table 1 Characteristics of patients in the training and testing cohorts

From: High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer

Characteristics

Training cohort (n = 99)

Testing cohort (n = 41)

With PNI (n = 23)

Without PNI (n = 76)

P value

With PNI (n = 9)

Without PNI (n = 32)

P value

Age, mean ± SD, years

63 ± 14

66 ± 9

0.400

66 ± 10

63 ± 9

0.421

Gender (%)

  

0.891

  

0.092

 Male

14 (60.9%)

45 (59.2%)

 

8 (88.9%)

22 (68.8%)

 

 Female

9 (39.1%)

31 (40.8%)

 

1 (11.1%)

10 (31.2%)

 

CEA, median (P25, P75), ng/mL

3.00 (1.16,4.80)

3.29 (1.87,7.12)

0.249

5.10 (3.46,18.87)

2.89 (1.76,8.61)

0.127

CA199, median (P25, P75), ng/mL

9.65 (5.30,15.83)

12.42 (7.55,18.76)

0.335

10.77 (6.71,20.65)

14.26 (8.42,21.51)

0.496

Histologic grade

  

0.078

  

0.025

 Well differentiated

1 (4.3%)

15 (19.7%)

 

0 (0)

5 (15.6%)

 

 Moderately differentiated

18 (78.3%)

53 (69.7%)

 

6 (66.7%)

25 (78.1%)

 

 Poorly differentiated

4 (17.4%)

8 (10.5%)

 

3 (33.3%)

2 (6.3%)

 

Primary site

  

0.763

  

0.464

 Low

8 (34.8%)

28 (36.8%)

 

1 (11.1%)

8 (25.0%)

 

 Mid

9 (39.1%)

31 (40.8%)

 

3 (33.3%)

10 (31.3%)

 

 High

6 (26.1%)

17 (22.4%)

 

5 (55.6%)

14 (43.7%)

 

Longest diameter, mean ± SD, cm

5.71 ± 2.20

4.71 ± 1.97

0.041

5.22 ± 1.27

4.64 ± 1.90

0.161

mT-stage

  

< 0.00

  

0.089

 T1/T2

6 (26.1%)

55 (72.4%)

1

4 (44.4%)

24 (75.0%)

 

 T3

17 (65.4%)

21 (27.6%)

 

5 (55.6%)

8 (25.0%)

 

mLN-status

  

0.187

  

0.507

 N0

10 (43.5%)

45 (59.2%)

 

7 (77.8%)

21 (65.6%)

 

 N1-N2

13 (56.5%)

31 (40.8%)

 

2 (22.2%)

11 (34.4%)

 

CRM

  

0.149

  

0.023

 Positive

9 (39.1%)

18 (23.7%)

 

6 (66.7%)

8 (25.0%)

 

 Negative

14 (60.9%)

58 (76.3%)

 

3 (33.3%)

24 (75.0%)

 

EMVI

  

0.008

  

0.637

 Positive

11 (47.8%)

15 (19.7%)

 

3 (33.3%)

8 (25.0%)

 

 Negative

12 (52.2%)

61 (80.3%)

 

6 (66.7%)

24 (75.0%)

 
  1. P-value for each radiomic feature associated with PNI was calculated using Wilcoxon test
  2. Abbreviations: PNI perineural invasion, CEA carcinoembryonic antigen, CA19–9 carbohydrate antigen 19–9, mT-stage MRI reported T-stage, mLN-status MRI lymph node-status, CRM circumferential resection margin, EMVI extramural vascular invasion